| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO And Director | CEO,CSO And Director | Chief Scientific Officer
1 company
Foster Robert T is a CEO And Director at Hepion Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 4 buys and 0 sells.
Estimated insider holdings value: $4K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 18, 2023 | HEPA Hepion Pharmaceuticals, Inc. | CEO And Director | Buy | 1,600 | $5.60 | $8,960.00 | +3.3% | |
| Sep 15, 2023 | HEPA Hepion Pharmaceuticals, Inc. | CEO,CSO And Director | Buy | 1,600 | $5.40 | $8,640.00 | +3.4% | |
| Feb 18, 2021 | HEPA Hepion Pharmaceuticals, Inc. | CEO And Director | Buy | 20,000 | $2.00 | $40,000.00 | +79.2% | |
| Dec 8, 2020 | HEPA Hepion Pharmaceuticals, Inc. | CEO And Director | Buy | 25,000 | $1.58 | $39,417.50 | +9,653% |